Cancer cells can activate the hemostatic system through the expression of pro-coagulant factors including tissue factor and cancer pro-coagulant, release of inflammatory cytokines (i.e., TNF-α, IL-1β) and microparticles, and adhesion to host vascular cells (Figure 1) (7–9). Here, TNF is linked to cancer.